Left ventricular assist device as a bridge to patient and myocardial recovery

Progress in Cardiovascular Diseases

Volumn 43, Issue 1, 2000, Pages 5-18

  Jaski, Brian E ^a,b   Lingle, Robert J ^a   Reardon, Leigh C ^a   Dembitsky, Walter P ^a  

^a San Diego Cardiac Center   (United States)

^b Address Reprint Requests Brian Jaski   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSISTED CIRCULATION; DEVICE; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEMODYNAMIC PARAMETERS; HUMAN; QUALITY OF LIFE; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0033944135     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2000.7193     Document Type: Article

References (46)

1. Levin HR, Weisfeldt ML. Deep thoughts on tin men. Fact, fallacy, and future of mechanical circulatory support. Circulation. 95:1997;2340-2343
2. Massie BM. Exercise tolerance in congestive heart failure. Role of cardiac function, peripheral blood flow, and muscle metabolism and effect of treatment. Am J Med. 84:1988;75-82
3. Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation. 87:1993;470-475
4. Wilson JR, Martin JL, Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: Role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol. 53:1984;1308-1315
5. Mancini DM, Henson D, LaManca J, et al. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation. 86:1992;909-918
6. Mancini DM. Pulmonary factors limiting exercise capacity in patients with heart failure. Prog Cardiovasc Dis. 37:1995;347-370
7. Wilson JR, Frey MJ, Mancini DM, et al. Sympathetic vasoconstriction during exercise in ambulatory patients with left ventricular failure. Circulation. 79:1989;1021-1027
8. Hirsch AT, Dzau VJ, Creager MA. Baroreceptor function in congestive heart failure: Effect on neurohumoral activation and regional vascular resistance. Circulation. 75:1987;IV36-IV48
9. Sullivan MJ, Knight JD, Higginbotham MB, et al. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 80:1989;769-781
10. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management. Am Heart J. 133:1997;703-712
11. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 81:1990;1161-1172
12. Cohn JN. Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation. 91:1995;2504-2507
13. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 57:1985;84-95
14. Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 319:1988;80-86
15. Sabbah HN, Shimoyama H, Kono T, et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation. 89:1994;2852-2859
16. McDonald KM, Rector T, Carlyle PF, et al. Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. J Am Coll Cardiol. 24:1994;1762-1768
17. Mulder P, Richard V, Derumeaux G, et al. Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation. 96:1997;1976-1982
18. Mann DL, Kent RL, Parsons B, et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85:1992;790-804
19. Tan LB, Jalil JE, Pick R, et al. Cardiac myocyte necrosis induced by angiotensin II. Circ Res. 69:1991;1185-1195
20. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241
21. Mann DL. The effect of tumor necrosis factor-alpha on cardiac structure and function: A tale of two cytokines. J Card Fail. 2:1996;S165-S172
22. Ono K, Matsumori A, Shioi T, et al. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation. 98:1998;149-156
23. Zhou G, Kandala JC, Tyagi SC, et al. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem. 154:1996;171-178
24. Weber KT. Extracellular matrix remodeling in heart failure: A role for de novo angiotensin II generation. Circulation. 96:1997;4065-4082
25. Yue P, Massie BM, Simpson PC, et al. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol. 275:1998;H250-H258
26. Jaski BE, Kim J, Maly RS, et al. Effects of exercise during long-term support with a left ventricular assist device. Results of the experience with left ventricular assist device with exercise (EVADE) pilot trial. Circulation. 95:1997;2401-2406
27. Levin HR, Oz MC, Chen JM, et al. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 91:1995;2717-2720
28. Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 62:1996;675-681
29. Zafeiridis A, Jeevanandam V, Houser SR, et al. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 98:1998;656-662
30. Altemose GT, Gritsus V, Jeevanandam V, et al. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant. 16:1997;765-773
31. McCarthy PM, Nakatani S, Vargo R, et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg. 59:1995;609-613
32. Jaski BE, Lingle RJ, Kim J, et al. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: Results of the experience with left ventricular assist device with exercise (EVADE) trial. J Heart Lung Transplant. 18:1999;1031-1040
33. Kobashigawa JA, Leaf DA, Lee N, et al. A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med. 340:1999;272-277
34. Dew MA, Kormos RL, Roth LH, et al. Life quality in the era of bridging to cardiac transplantation. Bridge patients in an outpatient setting. ASAIO J. 39:1993;145-152
35. Moskowitz AJ, Weinberg AD, Oz MC, et al. Quality of life with an implanted left ventricular assist device. Ann Thorac Surg. 64:1997;1764-1769
36. Burnett CM, Duncan JM, Frazier OH, et al. Improved multiorgan function after prolonged univentricular support. Ann Thorac Surg. 55:1993;65-71
37. Farrar DJ, Hill JD. Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant. 13:1994;1125-1132
38. Ashton RCJ, Goldstein DJ, Rose EA, et al. Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant. 15:1996;1151-1157
39. Muller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 96:1997;542-549
40. Scheinin SA, Capek P, Radovancevic B, et al. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J. 38:1992;M271-M274
41. Nakatani S, McCarthy PM, Kottke-Marchant K, et al. Left ventricular echocardiographic and histologic changes: Impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol. 27:1996;894-901
42. Dipla K, Mattiello JA, Jeevanandam V, et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 97:1998;2316-2322
43. Dembitsky WP, Moore CH, Holman WL, et al. Successful mechanical circulatory support for noncoronary shock. J Heart Lung Transplant. 11:1992;129-135
44. Pietsch L, Laube H, Baumann G, et al. Recovery from end-stage ischemic cardiomyopathy during long-term LVAD support. Ann Thorac Surg. 66:1998;555-557
45. Loebe M, Hennig E, Muller J, et al. Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement. Eur J Cardiothorac Surg. 11:(Suppl):1997;S18-24-S18-S24
46. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 98:1998;2383-2389